|
Market Closed -
Nasdaq Stockholm
20:00:00 04/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 1.360 SEK | -0.73% |
|
-55.56% | -96.56% |
| 08-19 | Biosergen AB Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 06-30 | Biosergen AB Appoints Mattias Klintemar as Chairman of the Board | CI |
| Market Cap | 3.19M 334K 287K 270K 247K 462K 31.52M 463K 1.24M 16.17M 1.25M 1.23M 52.09M | P/E 2024 |
-6.63x | P/E 2025 | -2.44x |
|---|---|---|---|---|---|
| Enterprise Value | -12.17M -1.27M -1.09M -1.03M -941K -1.76M -120M -1.77M -4.72M -61.64M -4.78M -4.67M -199M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
1.21% | Yield 2024 * |
-
| Yield 2025 | - |
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| BIOSGN | Delayed | |
Deutsche Boerse AG
| 8N10 | Delayed |
| 1 day | -0.73% | ||
| 1 week | -55.56% | ||
| Current month | -44.26% | ||
| 1 month | -75.71% | ||
| 3 months | -84.72% | ||
| 6 months | -96.46% | ||
| Current year | -96.56% |
| 1 week | 1.16 |  | 3.54 |
| 1 month | 0.7 | | 7.3 |
| Current year | 0.7 | | 47.8 |
| 1 year | 0.7 | | 55.2 |
| 3 years | 0.7 | | 199 |
| 5 years | 0.7 | | 992 |
| 10 years | 0.7 | | 2,300 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tine Kold Olesen
CEO | Chief Executive Officer | - | 01/02/2024 |
Mark Beveridge
DFI | Director of Finance/CFO | 48 | 24/07/2025 |
Peder Andersen
CEO | Chief Executive Officer | 74 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Marianne Kock
BRD | Director/Board Member | 71 | 01/01/2021 |
| Director/Board Member | 59 | 01/01/2021 | |
Anna Ljung
CHM | Chairman | 46 | 14/06/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.73% | -55.56% | -97.11% | -98.40% | 334K | |
| -1.79% | -2.27% | +50.90% | +89.03% | 67.98B | |
| -2.06% | -0.18% | +41.53% | +88.17% | 64.94B | |
| -0.31% | +6.54% | -11.39% | +457.82% | 27.58B | |
| -3.00% | -2.90% | +39.40% | +9.41% | 25.74B | |
| +0.86% | +1.65% | +0.25% | -14.78% | 26.06B | |
| -1.46% | +0.42% | +24.07% | -18.70% | 20.09B | |
| -2.96% | -15.21% | +210.71% | +370.84% | 17.16B | |
| -1.49% | -4.88% | -0.41% | +530.26% | 14.92B | |
| -0.20% | +8.37% | +57.87% | +159.50% | 14.62B | |
| Average | -1.31% | -5.32% | +31.58% | +157.31% | 27.91B | |
| Weighted average by Cap. | -1.52% | +0.18% | +42.29% | +145.08% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -19.2M -2.01M -1.73M -1.62M -1.48M -2.78M -189M -2.78M -7.45M -97.19M -7.53M -7.37M -313M | -38.01M -3.97M -3.42M -3.22M -2.94M -5.5M -375M -5.51M -14.75M -192M -14.92M -14.59M -620M |
| Net Debt | -50.61M -5.29M -4.55M -4.28M -3.91M -7.32M -499M -7.34M -19.64M -256M -19.87M -19.43M -826M | -15.37M -1.61M -1.38M -1.3M -1.19M -2.22M -152M -2.23M -5.96M -77.81M -6.03M -5.9M -251M |
Employees
1
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | SEK 1.360 | -0.73% | 435,138 |
| 03/09/26 | SEK 1.370 | -6.16% | 84,507 |
| 02/09/26 | SEK 1.460 | -7.59% | 504,614 |
| 01/09/26 | SEK 1.580 | -35.25% | 400,808 |
| 31/08/26 | SEK 2.440 | -20.26% | 698,432 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIOSGN Stock
Select your edition
All financial news and data tailored to specific country editions
